Showing 61 - 80 results of 457 for search '"patents"', query time: 0.06s Refine Results
  1. 61

    Optimal Operational Decision Making of Manufacturers and Authorized Remanufacturers with Patent Licensing under Carbon Cap-and-Trade Regulations by Biyu Liu, Zhongsheng Hua, Qinhong Zhang, Haidong Yang, Athanasios Migdalas

    Published 2020-01-01
    “…Constrained by production capacity and the pressure to reduce emissions, many original equipment manufacturers (OEMs) authorize third-party remanufacturers (TPRs) to remanufacture patented products. We investigate the operational decisions of OEMs and authorized TPRs under carbon cap-and-trade regulations in a two-echelon supply chain. …”
    Get full text
    Article
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66

    A Retrospective Analysis of Self-Limiting Fever following Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure by Francesca Galasso, Felicia Wassenaar, Timothy Barry, Omar J. Baqal, Donald J. Hagler, John P. Sweeney, F. David Fortuin

    Published 2024-01-01
    “…While percutaneous closure of patent foramen ovale (PFO) and atrial septal defect (ASD) are generally well-tolerated procedures, the development of postprocedure fever has been observed at a higher frequency than reported in the initial device trials. …”
    Get full text
    Article
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77

    Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results—Do We Have the Proper Device? by Michal Galeczka, Malgorzata Szkutnik, Jacek Bialkowski, Sebastian Smerdzinski, Mateusz Knop, Adam Sukiennik, Roland Fiszer

    Published 2020-01-01
    “…Objectives. Patent ductus arteriosus (PDA) in elderly patients is an uncommon anomaly, and the duct itself is often calcified and fragile; therefore, transcatheter closure is more difficult. …”
    Get full text
    Article
  18. 78

    Left Pulmonary Artery Stenting for Left Pulmonary Artery Stenosis Following Patent Ductus Arteriosus Device Closure: Case Series and Review of the Literature by Víctor Molina, Mehdi Hadid, Joaquim Miró, Nagib Dahdah

    Published 2024-01-01
    “…Percutaneous device occlusion is currently the standard of care for most cases of patent ductus arteriosus (PDA). Albeit infrequent, device-related left pulmonary artery (LPA) stenosis is a known complication of this procedure, occasionally requiring stent placement to relieve the obstruction. …”
    Get full text
    Article
  19. 79

    Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable? by Susan J. Skledar, Brian A. Williams, Manuel C. Vallejo, Patricia L. Dalby, Jonathan H. Waters, Ronald Glick, Michael L. Kentor

    Published 2007-01-01
    “…At the end of surgery, ondansetron (4 mg i.v., now off-patent) is added. Rescue therapy consists of avoiding unnecessary repeat doses of drugs acting by the same mechanism: haloperidol 2 mg i.v. …”
    Get full text
    Article
  20. 80